The strategic decision to end further internal development of the ex-Novartis asset, dubbed naporafenib, will allow Erasca to ...

By Daniella Parra Jeito Capital said it is leading a €132 million oversubscribed Series B funding round in Azafaros, a ...

Bluebird bio shareholders have dragged their feet in tendering shares as part of the company’s sale process, prompting buyers ...

Viking Therapeutics became famous in the biotech world last year after announcing positive phase 2 results for VK2735, an investigational GLP-1 weight loss candidate. The stock has not performed well ...

The company had also said last month that Paul Stoffels, a pharma legend who took on the CEO role in 2022 in a bid to ...

To­day on Post Hoc Live, Drew Arm­strong is joined by Nick Ship­ley, the for­mer top lob­by­ist for the biotech in­dus­try, ...

San Diego is rapidly emerging as a major part of California’s life sciences industry. By the end of 2025, the completion of ...

We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at ...

We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at ...

We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at ...

Mswipe acquisition, expected to close early in Q2, will be immediately accretive upon close to revenue and EBITDA Payment Card offering, already integrated with ALT5 Pay, to be immediately made ...